Role of PI3K/Akt/GSK-3 Pathway in Emesis and Potential New Antiemetics
- PMID: 33426544
- PMCID: PMC7793561
- DOI: 10.33696/Signaling.1.024
Role of PI3K/Akt/GSK-3 Pathway in Emesis and Potential New Antiemetics
Keywords: Akt; Ca2+; Chemotherapy; Emesis; Emetic nuclei; GSK-3; PI3K.
Conflict of interest statement
Conflicts of Interest We have no conflict of interest to declare.
Similar articles
-
The pivotal role of glycogen synthase kinase 3 (GSK-3) in vomiting evoked by specific emetogens in the least shrew (Cryptotis parva).Neurochem Int. 2020 Jan;132:104603. doi: 10.1016/j.neuint.2019.104603. Epub 2019 Nov 15. Neurochem Int. 2020. PMID: 31738972 Free PMC article.
-
Isorhynchophylline exerts antidepressant-like effects in mice via modulating neuroinflammation and neurotrophins: involvement of the PI3K/Akt/GSK-3β signaling pathway.FASEB J. 2019 Sep;33(9):10393-10408. doi: 10.1096/fj.201802743RR. Epub 2019 Jun 24. FASEB J. 2019. PMID: 31233346
-
Treadmill exercise activates PI3K/Akt signaling pathway leading to GSK-3β inhibition in the social isolated rat pups.J Exerc Rehabil. 2018 Feb 26;14(1):4-9. doi: 10.12965/jer.1836054.027. eCollection 2018 Feb. J Exerc Rehabil. 2018. PMID: 29511646 Free PMC article.
-
Emesis and anti-emesis.Cancer Surv. 1994;21:117-35. Cancer Surv. 1994. PMID: 8564988 Review.
-
Controlling cancer chemotherapy-induced emesis. An update.Pharm Weekbl Sci. 1991 Oct 18;13(5):189-97. doi: 10.1007/BF01988874. Pharm Weekbl Sci. 1991. PMID: 1749707 Review.
Cited by
-
Downregulation of AKT-mediated p27Kip1 phosphorylation with shift to sphingomyelin synthesis in CLN3 disease.IBRO Neurosci Rep. 2025 Jun 27;19:223-234. doi: 10.1016/j.ibneur.2025.06.005. eCollection 2025 Dec. IBRO Neurosci Rep. 2025. PMID: 40678187 Free PMC article.
-
Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.Int J Mol Sci. 2021 May 28;22(11):5797. doi: 10.3390/ijms22115797. Int J Mol Sci. 2021. PMID: 34071460 Free PMC article. Review.
References
-
- Adel N Overview of chemotherapy-induced nausea and vomiting and evidence-based therapies. The American Journal of Managed Care. 2017. September;23(14 Suppl):S259. - PubMed
-
- Navari RM, Aapro M. Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. New England Journal of Medicine. 2016. April 7;374(14):1356–67. - PubMed
-
- Hesketh PJ. Chemotherapy-induced nausea and vomiting. New England Journal of Medicine. 2008. June 5;358(23):2482–94. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous